Literature DB >> 9811080

Aerosolized vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.

L Máiz1, R Cantón, N Mir, F Baquero, H Escobar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9811080     DOI： 10.1002/(sici)1099-0496(199810)26:4<287::aid-ppul9>3.0.co;2-#

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN： 1099-0496


× No keyword cloud information.
  9 in total

Review 1.  Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp.

Authors:  Andrew M Jones; A Kevin Webb
Journal:  J R Soc Med       Date:  2003       Impact factor: 5.344

2.  Microparticles for inhalational delivery of antipseudomonal antibiotics.

Authors:  Michael D Tsifansky; Yoon Yeo; Oleg V Evgenov; Evangelia Bellas; John Benjamin; Daniel S Kohane
Journal:  AAPS J       Date:  2008-05-03       Impact factor: 4.009

3.  Inhaled antimicrobial therapies for respiratory infections.

Authors:  Shin-Woo Kim; Joseph L Kuti; David P Nicolau
Journal:  Curr Infect Dis Rep       Date:  2008-03       Impact factor: 3.725

4.  Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis.

Authors:  L S Miall; N T McGinley; K G Brownlee; S P Conway
Journal:  Arch Dis Child       Date:  2001-02       Impact factor: 3.791

5.  In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: implications of the innate immune response.

Authors:  E López-Collazo; T Jurado; J de Dios Caballero; M Pérez-Vázquez; A Vindel; E Hernández-Jiménez; J Tamames; C Cubillos-Zapata; M Manrique; R Tobes; L Máiz; R Cantón; F Baquero; R Del Campo
Journal:  Mucosal Immunol       Date:  2014-08-13       Impact factor: 7.313

Review 6.  Nebulized antibiotics in cystic fibrosis.

Authors:  Isabelle Sermet-Gaudelus; Yann Le Cocguic; Agnés Ferroni; Marlène Clairicia; Joel Barthe; Jan-Pierre Delaunay; Valentine Brousse; Gérard Lenoir
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  Pulmonary versus systemic delivery of antibiotics: comparison of vancomycin dispositions in the isolated rat lung.

Authors:  María José de Jesús Valle; Francisco González López; Alfonso Domínguez-Gil Hurlé; Amparo Sánchez Navarro
Journal:  Antimicrob Agents Chemother       Date:  2007-08-06       Impact factor: 5.191

8.  Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol.

Authors:  Paul Zarogoulidis; Ioannis Kioumis; Sofia Lampaki; John Organtzis; Konstantinos Porpodis; Dionysios Spyratos; Georgia Pitsiou; Dimitris Petridis; Athanasia Pataka; Haidong Huang; Qiang Li; Lonny Yarmus; Wolfgang Hohenforst-Schmidt; Nikolaos Pezirkianidis; Konstantinos Zarogoulidis
Journal:  Drug Des Devel Ther       Date:  2014-08-12       Impact factor: 4.162

Review 9.  Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.

Authors:  David Kh Lo; Marianne S Muhlebach; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2018-07-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.